Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?
Abstract Background Despite price advantages, local direct-acting antiviral agents (DAAs) for hepatitis C (hep C) have not been widely used in China compared with the imported ones. There is no evidence on their relative efficacy and safety, nor whether the small market share of local DAAs was attri...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-07-01
|
| Rangatū: | Infectious Diseases of Poverty |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40249-025-01344-2 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|